Microsomal epoxide hydrolase polymorphisms, cigarette smoking and prostate cancer risk in the Slovak population

Neoplasma

Volumn 59, Issue 1, 2012, Pages 79-84

  Kmetova Sivonova, M ^a   Dobrota, D ^a   Matakova, T ^a   Dusenka, R ^a   Grobarcikova, S ^a   Habalova, V ^b   Salagovic, J ^b   Tajtakova, M ^b   Pidanicova, A ^b   Valansky, L ^b   Lachvac, L ^b   Kliment, ^a   Nagy, V ^b   Kliment, J ^a  

^a Physics and Informatics   (Slovakia)

^b P J AFÁRIK UNIVERSITY   (Slovakia)

Author keywords

Cigarette smoking; Genetic polymorphism; Microsomal epoxide hydrolase (EPHX1); Prostate cancer; Slovak population

Indexed keywords

EPOXIDE HYDROLASE; EPHX1 PROTEIN, HUMAN; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DNA EXTRACTION; ENZYME POLYMORPHISM; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; PROSTATE CANCER; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SLOVAKIA; SMOKING; ADENOCARCINOMA; AMINO ACID SUBSTITUTION; BIOTRANSFORMATION; ENZYMOLOGY; EXON; GENETIC PREDISPOSITION; GENETICS; MICROSOME; MIDDLE AGED; PROSTATE TUMOR; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENOCARCINOMA; ADULT; AGED, 80 AND OVER; AMINO ACID SUBSTITUTION; BIOTRANSFORMATION; CASE-CONTROL STUDIES; EPOXIDE HYDROLASES; EXONS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MICROSOMES; MIDDLE AGED; NEOPLASM PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; RISK; SLOVAKIA; SMOKING;

EID: 84863756188     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2012_010     Document Type: Article

References (34)

1. SCHRÖDER FH Prostate cancer around the world. An overview. Urol Oncol. 2010; 28: 663-667. http://dx.doi. org/10.1016/j.urolonc.2009.12.013
2. ONDRUSOVA M, ONDRUS D, KARABINOS J, MUZIK J, KLIMENT J et al. Trends in prostate cancer incidence and mortality before and after the introduction of PSA testing in the Slovak and Czech Republics. Tumori. 2011; 97: 149-155.
3. KRAL M, ROSINSKA V, STUDENT V, GREPL M, HRABEC M et al: Genetic determinants of prostate cancer: a review. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011; 155: 3-9. http://dx.doi.org/10.5507/bp.155.2011.001
4. AUTRUP H Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response. Mutat Res. 2000; 464: 65-76.
5. DUALE N, BJELLAAS T, ALEXANDER J, BECHER G, HAUGEN M et al. Biomarkers of human exposure to acrylamide and relation to polymorphisms in metabolizing genes. Toxicol Sci. 2009; 108: 90-99. http://dx.doi.org/10.1093/toxsci/kfn269
6. ARAND M, GRANT DF, BEETHAM JK, FRIEDBERG T, OESCH F et al. Sequence similarity of mammalian epoxide hydrolases to the bacterial haloalkane dehalogenase and other related proteins. Implication for the potential catalytic mechanism of enzymatic epoxide hydrolysis, FEBS Lett. 1994; 338: 251-256. http://dx.doi.org/10.1016/0014-5793(94)80278-5
7. OMIECINSKI CJ, HASSETT C, HOSAGRAHARA V Epoxide hydrolase-polymorphism and role in toxicology. Toxicol Lett. 2000 15; 112-113: 365-370.
8. SKODA RC, DEMIERRE A, MCBRIDE OW, GONZALEZ FJ, MEYER UA Human microsomal xenobiotic epoxide hydrolase. Complementary DNA sequence, complementary DNAdirected expression in COS-1 cells, and chromosomal localization. J Biol Chem 1988; 263: 1549-1554.
9. FRETLAND AJ, OMIECINSKI CJ Epoxide hydrolases: biochemistry and molecular biology. Chem Biol Interact. 2000; 129: 41-59. http://dx.doi.org/10.1016/S0009-2797(00)00197-6
10. COLLER JK, FRITZ P, ZANGER UM, SIEGLE I, EICHELBAUM M et al. Distribution of microsomal epoxide hydrolase in humans: an immunohistochemical study in normal tissues, and benign and malignant tumours. Histochem J 2001; 33: 329-336. http://dx.doi.org/10.1023/A:1012414806166
11. HUANG WY, CHATTERJEE N, CHANOCK S, DEAN M, YEAGER M et al. Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenoma. Cancer Epidemiol Biomarkers Prev. 2005; 14: 152-157.
12. CORTESSIS V, SIEGMUND K, CHEN Q, ZHOU N, DIEP A et al. A case-control study of microsomal epoxide hydrolase, smoking, meat consumption, glutathione S-transferase M3, and risk of colorectal adenomas. Cancer Res 2001; 61: 2381-2385.
13. ROTUNNO M, YU K, LUBIN JH, CONSONNI D, PESATORI AC et al. Phase I metabolic genes and risk of lung cancer: multiple polymorphisms and mRNA expression. PLoS One. 2009; 4: e5652. http://dx.doi.org/10.1371/journal.pone.0005652
14. WIDERSTEN M, GURELL A, LINDBERG D Structure-function relationships of epoxide hydrolases and their potential use in biocatalysis. Biochim Biophys Acta. 2010; 1800: 316-326.
15. CHENG SL, YU CJ, CHEN CJ, YANG PC Genetic polymorphism of epoxide hydrolase and glutathione S-transferase in COPD. Eur Respir J. 2004; 23: 818-824. http://dx.doi. org/10.1183/09031936.04.00104904
16. ROBIEN K, CURTIN K, ULRICH CM, BIGLER J, SAMOWITZ W et al. Microsomal epoxide hydrolase polymorphisms are not associated with colon cancer risk. Cancer Epidemiol Biomarkers Prev. 2005; 14: 1350-1352. http://dx.doi. org/10.1158/1055-9965.EPI-04-0877
17. HASSETT C, AICHER L, SIDHU JS, OMIECINSKI CJ Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet 1994; 3: 421-428. http://dx.doi.org/10.1093/hmg/3.3.421
18. MITTAL RD, SRIVASTAVA DL Cytochrome P4501A1 and microsomal epoxide hydrolase gene polymorphisms: gene-environment interaction and risk of prostate cancer. DNA Cell Biol. 2007; 26: 791-798. http://dx.doi.org/10.1089/dna.2007.0630
19. NOCK NL, LIU X, CICEK MS, LI L, MACARIE F et al. Polymorphisms in polycyclic aromatic hydrocarbon metabolism and conjugation genes, interactions with smoking and prostate cancer risk. Cancer Epidemiol Biomarkers Prev. 2006; 15: 756-761. http://dx.doi.org/10.1158/1055-9965.EPI-05-0826
20. NOCK NL, TANG D, RUNDLE A, NESLUND-DUDAS C, SAVERA AT et al. Associations between smoking, polymorphisms in polycyclic aromatic hydrocarbon (PAH) metabolism and conjugation genes and PAH-DNA adducts in prostate tumors differ by race. Cancer Epidemiol Biomarkers Prev. 2007; 16: 1236-1245. http://dx.doi.org/10.1158/1055-9965.EPI-06-0736
21. ZIDZIK J, SLABA E, JOPPA P, KLUCHOVA Z, DORKOVA Z et al. Glutathione S-transferase and microsomal epox ide hydrolase gene polymorphisms and risk of chronic obstructive pulmonary disease in Slovak population. Croat Med J. 2008; 49: 182-191. http://dx.doi.org/10.3325/cmj.2008.2.182
22. LONDON SJ, SMART J, DALY AK Lung cancer risk in relation to genetic polymorphisms of microsomal epoxide hydrolase among African-Americans and Caucasians in Los Angeles County. Lung Cancer. 2000; 28: 147-155. http://dx.doi.org/10.1016/S0169-5002(99)00130-0
23. TO-FIGUERAS J, GENE M, GOMEZ-CATALAN J, PIQUE E, BORREGO N et al: Lung cancer susceptibility in relation to combined polymorphisms of microsomal epoxide hydrolase and glutathione S-transferase P1. Cancer Lett. 2001; 173: 155-162. http://dx.doi.org/10.1016/S0304-3835(01)00626-7
24. GSUR A, ZIDEK T, SCHNATTINGER K, FEIK E, HAIDINGER G et al: Association of microsomal epoxide hydrolase polymorphisms and lung cancer risk. Br J Cancer. 2003; 89: 702-706. http://dx.doi.org/10.1038/sj.bjc.6601142
25. KHEDHAIER A, HASSEN E, BOUAOUINA N, GABBOUJ S, AHMED SB et al: Implication of Xenobiotic Metabolizing Enzyme gene (CYP2E1, CYP2C19, CYP2D6, mEH and NAT2) polymorphisms in breast carcinoma. BMC Cancer. 2008; 8: 109. http://dx.doi.org/10.1186/1471-2407-8-109
26. WANG Z, TANG L, SUN G, TANG Y, XIE Y et al: Etiological study of esophageal squamous cell carcinoma in an endemic region: a population-based case control study in Huaian, China. BMC Cancer. 2006; 6: 287. http://dx.doi.org/10.1186/1471-2407-6-287
27. HECHT SS, CHEN M, YAGI H, JERINA DM, CARMELLA SG r-1, t-2,3, c-4-Tetrahydroxy-1,2,3,4-tetrahydrophenanthrene in human urine: a potential biomarker for assessing polycyclic aromatic hydrocarbon metabolic activation. Cancer Epidemiol Biomarkers Prev. 2003; 12: 1501-1508.
28. RYBICKI BA, RUNDLE A, SAVERA AT, SANKEY SS, TANG D Polycyclic aromatic hydrocarbon-DNA adducts in prostate cancer. Cancer Res. 2004; 64(24): 8854-8859. http://dx.doi. org/10.1158/0008-5472.CAN-04-2323
29. TRANAH GJ, GIOVANNUCCI E, MA J, FUCHS C, HANKINSON SE et al. Epoxide hydrolase polymorphisms, cigarette smoking and risk of colorectal adenoma in the Nurses' Health Study and the Health Professionals Followup Study. Carcinogenesis. 2004; 25: 1211-1218. http://dx.doi. org/10.1093/carcin/bgh126
30. MITROU P, WATSON M, BINGHAM S, STEBBINGS WS, SPEAKMAN CT et al. NQO1 and mEH exon 4 (mEH4) gene polymorphisms, smoking and colorectal cancer risk. IARC Sci Publ. 2002; 156: 495-497.
31. FRANCO SS, NARDOCCI AC, GÜNTHER WM PAH biomarkers for human health risk assessment: a-review of the state-of-the-art. Cad Saude Publica. 2008; 24: 569-580.
32. OMIECINSKI CJ, HASSETT C, HOSAGRAHARA V Epoxide hydrolase polymorphism and role in toxicology. Toxicol Lett 2000; 112-113: 365-370. http://dx.doi.org/10.1016/S0378-4274(99)00235-0
33. SHIMADA T Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons. Drug Metab Pharmacokinet. 2006; 21: 257-76. http://dx.doi.org/10.2133/dmpk.21.257
34. GELHAUS SL, HARVEY RG, PENNING TM, BLAIR IA Regulation of benzo[a]pyrene-mediated DNA-and glutathione-adduct formation by 2,3,7,8-tetrachlorodibenzop-dioxin in human lung cells. Chem Res Toxicol. 2011; 24: 89-98. http://dx.doi.org/10.1021/tx100297z98.